KALA News and Press, Kala Pharmaceuticals Inc. From 03/24/20

Kala Pharmaceuticals ( KALA ) announced that it had achieved positive results from its phase 3 study using EYSUVIS for the treatment of patients with dry eye disease. It had trouble in the past with its first NDA of this drug, because it had received a CRL. Now that the biotech has been ...

InsiderInsights' Daily Round-Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

Tiziana Life Sciences PLC (NASDAQ: TLSA ) +162%  on potential coronavirus treatment . More news on: Tiziana Life Sciences PLC, Phio Pharmaceuticals Corp., Inovio Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Kala Pharmaceuticals (NASDAQ: KALA ) has priced its public offering of 16M common shares at $7.89 per share, for gross proceeds of ~$126.2M. More news on: Kala Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Kala Pharmaceuticals, Inc. (“Kala”) (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced today the pricing of an underwritten public offering of 16,000,000 shares of its ...

Kala Pharmaceuticals, Inc. (“Kala”) (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced today that it has commenced an underwritten public offering of $100.0 million of ...

Gainers:  Spherix (NASDAQ: SPEX ) +146% . More news on: Spherix Incorporated, AIM ImmunoTech Inc., LightPath Technologies, Inc., Stocks on the move, , Read more ...

Spherix (NASDAQ: SPEX ) +72% . More news on: Spherix Incorporated, AIM ImmunoTech Inc., Cocrystal Pharma, Inc., Stocks on the move, , Read more ...

Kala Pharmaceuticals (NASDAQ: KALA ) is up  13%  premarket on light volume in reaction to its announcement that a Phase 3 clinical trial, STRIDE 3 , evaluating lead candidate KPI-121 in patients with dry eye disease. More news on: Kala Pharmaceuticals, Inc., Healthcare stocks ...